|
HemoCath-guided healthcare for patients with heart failure has the potential to improve clinical outcomes and reduce hospital length of stay
|
HemoCath™ pulmonary artery catheter
Flow-directed monitoring PA catheter (4F) with two pressure micro-sensors
Inserted into the brachial vein on the arm (central vein access)
Substantially less invasive, more accurate and easier-to-use
Monitoring essential hemodynamic metrics:
Inserted into the brachial vein on the arm (central vein access)
Substantially less invasive, more accurate and easier-to-use
Monitoring essential hemodynamic metrics:
- central venous pressure (CVP)
- pulmonary artery pressure (PAP)
- pulmonary artery wedge pressure (PAWP)
- mixed venous oxygen saturation (SvO2)
- cardiac output (CO, using Fick principle)
HemoCath™ monitor
HemoCath-guided heart failure management
Direct simultaneous monitoring of CVP and PAP blood pressure
Calculating key hemodynamic parameters in real time (e.g. PAP index, mPAP, HR)
HemoCath PA catheter connected to HemoCath monitor
Easy-to-use graphical user interface
Direct simultaneous monitoring of CVP and PAP blood pressure
Calculating key hemodynamic parameters in real time (e.g. PAP index, mPAP, HR)
HemoCath PA catheter connected to HemoCath monitor
Easy-to-use graphical user interface
HemoCath™ PA catheter positioned into a pulmonary artery
Clinical Need
Current diagnostic methods (e.g. physical exams, lab tests, medical imaging) and devices (e.g. today's PA catheters, electronic cardiac implants) each have shortcomings to assess heart failure in patients. The HemoCath PA catheter is designed to address this clinical need for patients with heart failure.